dox-oh-ROO-bi-sin
Doxorubicin kills cancer cells.
This medicine may be called by the brand names, Adriamycin® and Rubex®.
Doxorubicin is injected into the veins.
Doxorubicin can decrease the number of white blood cells in your body, cells that usually help you fight infections. It can also decrease the number of cells in your blood that help your blood clot (platelets) and the number of red blood cells, cells that carry oxygen to your tissues. Without enough red blood cells, the tissues get less oxygen and you could become fatigued. Ask your doctor, nurse, or pharmacist how to reduce your risk of infection, excessive bleeding, or fatigue.
Tell the doctor or nurse right away if you have redness, pain, or swelling at the injection site. If doxorubicin leaks out of the vein it is injected into, it can damage the tissue and cause scarring.
Drink extra fluids while you are getting doxorubicin so you will urinate more and your kidneys will work well.
Doxorubicin may turn your urine a reddish color for 1-2 days after you get each dose. Although this is not blood, it may stain clothes and bedding.
Call your doctor if you are worried about a side effect or have questions about your medical care.
Call the doctor at once if you have any of these side effects:
Call the doctor as soon as you can if you have any of these side effects:
Doxorubicin may cause side effects that do not occur for months or years after you finish chemotherapy, including leukemia or heart problems. Heart failure can occur in patients who get large doses of doxorubicin or similar chemotherapy drugs during their lifetime. The risk of heart failure is higher if you have chest radiation during your therapy. Discuss these long-term effects with your doctor if you are concerned.
These written patient information materials should be used in conjunction with verbal counseling. They are not intended as the sole source of information patients receive about their chemotherapy and other medications. The adverse effects listed are important and common ones that patients might experience; every possible adverse effect is not included. Long-term adverse effects, like secondary malignancy and infertility, are discussed for those drugs whose risk is well defined.